HTDS - Hard To Treat Diseases Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HTDS - Hard To Treat Diseases

HTDS 0.000001000

-95.0%

May 28 12:33 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: jmhollen	3/29/2005 12:15:06 PM
	of 271

From RB: The Shinn shares have FINALLY been canceled. According to my sources, the total outstanding shares as of today is about 356 million. While this action has no bearing on the "float", as the Shinn shares were frozen & could not be sold, it is VERY POSITIVE as to HTDS's total market capitalization. The canceled Shinn shares could indicate that a negotiated settlement may be reached in the near future. If not, the trial & resolution of the litigation is just a little over a month away. Once HTDS is ruled to have exclusive marketing rights to Tubercin & T-19 the stock price could explode, as the total market cap has been drastically reduced. ragingbull.lycos.com .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next